Genentech Starts Pulling Back Psoriasis Drug

Wednesday, April 8, 2009 - 22:56 in Health & Medicine

Raptiva, which had 2008 sales of $108 million in the United States, has been linked to a brain infection.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net